Clinical Trial Update: Systemic Inflammation and Obstructive Sleep Apnea Syndrome: Effect of Atorvastatin [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the effect of atorvastatin on systemic inflammation in obstructive sleep apnea; the study was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obstructive Sleep Apnea

Drugs mentioned

• Lipitor (atorvastatin)

Snippet

Sponsor: University Hospital, Grenoble | Conditions: Obstructive Sleep Apnea Syndrome | Phase 2 | Status: TERMINATED